Skip to main content
SpringerLink
Log in

Heparin in the Prevention and Treatment of Arterial Thromboembolism

  • Chapter
Heparin and Related Polysaccharides

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 313))

Abstract

The aim of treatment of thromboembolic occlusion is prompt restoration of blood flow. Ideal treatment of thrombosis is therefore to remove the obstruction. If this is not possible, treatment should ensure that the thrombus does not extend or generate an embolus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • ACC/NHLBI, 1986, National conference on antithrombotic therapy, Chest, 89 (Suppl): S1.

    Google Scholar 

  • Altman, R., Rouvier, J., Gurfinkel, E., D’Ortencio, O., Manzanel, R., de la Fuente, L., and Favaloro, R. G., 1991, Comparison of two levels of anticoagulant therapy in patients with substitute heart valve, J. Thorac. Cardiovasc. Surg., 101: 427.

    PubMed  CAS  Google Scholar 

  • Arvan, S., and Boscha, K., 1987, Prophylactic anticoagulation for left ventricular thrombi after acute myocardial infarction: a prospective randomised trial, Am. Heart J., 113: 688.

    Article  PubMed  CAS  Google Scholar 

  • Bleich, S. D., Nichols, T., Schumacher, R., Cooke, D., Tate, D., and Brinkman, D., 1990, The role of heparin following coronary thrombolysis with tissue plasminogen activator (t-PA), Am. J. Cardiol., 66: 1412.

    Article  PubMed  CAS  Google Scholar 

  • Cleland, J., and Molloy, P. J., 1973, Thromboembolic complications of the cloth-covered Starr-Edwards prostheses no. 2300 aortic and no. 6300 mitral, Thorax, 28: 41.

    Article  PubMed  CAS  Google Scholar 

  • Chesebro, J. H., and Fuster, V., 1991, Valvular heart diseases and prosthetic heart valves, in: “Thrombosis in Cardiovascular Disorders”, V. Fuster, and M. Verstraete, eds., W.B. Saunders, in press.

    Google Scholar 

  • Cohn, L. H., Allred, E. N., Cohn L. A., Austin, J. C., Sabik, J., DiSesa, V. J., Shemin, R. J., and Collins Jr., J. J., 1985, Early and late risk of mitral valve replacement: a 12 year concomitant comparison of the porcine bioprosthetic and prosthetic disc mitral valves, J. Thorac. Cardiovasc. Surq., 90: 872.

    CAS  Google Scholar 

  • de Bono, D. P., Simoons, M. L., Tijssen, J., Arnold, A. E. R., Betriu, A., Burgersdijk, C, Bescos, L. L., Mueller, E., Pfisterer, M., Van De Werf, F., Zijlstra, F., and Verstraete, M., for the ECSG, 1991, Early intravenous heparin enhances coronary patency after alteplase thrombolysis: results of a randomized double blind European Cooperative Study Group Trial, Br. Heart J., in press.

    Google Scholar 

  • Eisenberg, P. R., Sherman, L., Rich, M., Schwartz, D., Schectman, K., Geltman, E. M., Sobel, B. E., and Jaffe, A. S., 1986, Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis, J. Am. Coll. Cardiol., 7: 1255.

    Article  PubMed  CAS  Google Scholar 

  • Davis, M. J. E., and Ireland, M., 1986, Effects of early anticoagulation on the frequency of left ventricular thrombi after anterior wall acute myocardial infarction, Am. J. Cardiol., 57: 1244.

    Article  PubMed  CAS  Google Scholar 

  • Douglas, P., Hirshfeld, J. W., and Edmunds, L. H., 1984, Clinical correlates of post-operative atrial fibrillation (abstr), Circulation, 70(Suppl II): 11–165.

    Google Scholar 

  • Drapkin, A., and Merskey, C., 1972, Anticoagulant therapy after acute myocardial infarction: relation of therapeutic benefit to patient’s age and severity of infarction, J. Am. Hed. Assoc., 222: 541.

    Article  CAS  Google Scholar 

  • Friedli, B., Aerichide, N., Grondin, P., and Campeau, L., 1971, Thromboembolic complications of heart valve replacement, Am. Heart J., 81: 702.

    Article  PubMed  CAS  Google Scholar 

  • Funke Kupper, A. J., Verheugt, F. W. A., and Peels, C. H., 1989, Left ventricular thrombus incidence and behavior studied by serial two-dimensional echocardiography in acute anterior myocardial infarction: left ventricular wall motion, systemic embolism and oral anti-coagulation, J. Am. Coll. Cardiol., 13: 1514.

    Article  Google Scholar 

  • Fuster, V., Pumphrey, C. W., McGoon, M. D., Chesebro, J. H., Pluth, J. R., and McGoon, D. C., 1982, Systemic thromboembolism in mitral and aortic Starr-Edwards prostheses: A 10–19 year follow-up, Circulation, 66(Suppl I): 157.

    Google Scholar 

  • Gruppo Italiano per lo Studio dell a sopravvivenza nell Infarto Miocardioco, 1990, GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 127490 patients with acute myocardial infarction, Lancet, 336: 65.

    Google Scholar 

  • Gueret, P., Dubourg, O., Ferrier, A., Farcot, J. R., Rigaud, M., and Bourdanas, J. P., 1986, Effects of full dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural mycoardial infarction, J. Am. Coll. Cardiol., 8: 416.

    Article  Google Scholar 

  • Hilden, T., Iversen, K., Raaschou, F., et al., 1961, Anticoagulation in acute myocardial infarction, Lancet. 2: 327.

    Article  PubMed  CAS  Google Scholar 

  • Hsia, J., Hamilton, W. P., Kleiman, N., Roberts, R., Chaitman, B. R., and Ross, A. M., (1990), A randomized trial of heparin versus aspirin adjunctive to tissue plasminogen activator-induced thrombolysis for acute myocardial infarction, N. Engl. J. Med., 323, 1433.

    Article  PubMed  CAS  Google Scholar 

  • Kothari, A. J., Paczkowski, K., Baker, K. M., et al., 1984, Ventricular thrombi in acute myocardial infarction: incidence, complications and effects of anticoagulation, J. Am. Coll. Cardiol., 3 (Suppl.): 601.

    Google Scholar 

  • Nordrehaug, J. E., Johannessen, K.A., and von der Lippe, G., 1985, Usefullness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction, Am. J. Cardiol., 55: 1491.

    Article  PubMed  CAS  Google Scholar 

  • Owen, J., Friedman, K. D., Grossmann, B. A., Wilkins, C., Berke, A. D., and Powers, E. R., 1988, Thrombolytic therapy with tissue-type plasminogen activator or streptokinase induces transient thrombus activity. Blood, 72: 616.

    PubMed  CAS  Google Scholar 

  • Serneri, G. G. N., Abbate, R., Prisco, D., Carnovali, M., Fazi, A., Casolo, G. C., Bonechi, F., Rogasi, P. G., and Gensini, G. F., 1988, Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: a controlled cross-over randomized trial, Am. Heart J., 115: 60.

    Article  Google Scholar 

  • Serneri, G. G. N., Gensini, G. F., Carnovalli, M., Rovelli, F., Pirelli, S., and Fortinin, A., 1987, Effectiveness of low-dose heparin in prevention of myocardial infarction, Lancet, i: 937.

    Article  Google Scholar 

  • Serneri, G. G. N., Gensini, G. F., Poggesi, L., Trotta, F., Modesti, P. A., Boddi, M., Teri, A., Margheri, M., Casolo, G. C., Bini, M., et al., 1990, Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina, Lancet. 335: 615.

    Article  Google Scholar 

  • Sleight, P., 1991, Preliminary outcome data. ISIS-3 presented at the American College of Cardiology Annual Scientific Meeting, March 1991, Atlanta, GA.

    Google Scholar 

  • Penny, W. J., Chesebro, J. H., Heras, M., and Fuster, V., 1988, Antithrombotic therapy for patients with cardiac disease, Curr. Probl. Cardiol., 13, 644.

    Google Scholar 

  • Rapold, H. J., Kuemmerli, H., Weiss, M., Baur, H., and Haeberli, A., 1989, Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator, Circulation, 79: 980.

    Article  PubMed  CAS  Google Scholar 

  • Rapold, H. J., de Bono, D., Arnold, A. E. R., Tijssen, J., De Cock, F., Collen, D., and Verstraete, M., for the European Cooperative Study Group, 1991, Fibrinopeptide A plasma levels and the significance of adequate anticoagulation for coronary patency, recurrent ischemia and left ventricular thrombosis in patients with acute myocardial infarction treated with alteplase, Circulation, in press.

    Google Scholar 

  • Stroke Prevention in Atrial Fibrillation Study Group Investigators, 1990, Preliminary report of the SPAF Study, N. Enql. J. Med., 322: 863.

    Google Scholar 

  • Tebbe, U., 1990, A randomized trial of heparin versus placebo after prourokinase induced thrombolysis. Presented at the George Washington University 6th International Workshop on Thrombolysis and Interventional Therapy in Acute Myocardial Infarction, Dallas, Texas, November 1990.

    Google Scholar 

  • Telford, A. M., and Wilson, C., 1981, Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome, Lancet, 1: 1225.

    Article  PubMed  CAS  Google Scholar 

  • The International Study Group, 1990, In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin, Lancet, 336: 71.

    Article  Google Scholar 

  • The RISK Group, 1990, Risk of myocardial infarction and death during treatment with low-dose aspirin and intravenous heparin in men with unstable coronary artery disease, Lancet, 336: 827.

    Article  Google Scholar 

  • Théroux, P., Quimet, H., and McCans, J., 1988, Aspirin, heparin, or both to treat acute unstable angina? N. Enql. J. Med.,1988, 319: 1105.

    Article  Google Scholar 

  • The SCATI (Studio della Calciparina nell’angina e nella Trombosi Ventricolare nell’infarto) group, 1989, Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction, Lancet, ii: 182.

    Google Scholar 

  • Topol, E. J., George, B. S., Kereiakes, D. J., Stump, D. C., Candela, R. J., Abbottsmith, C. W., Aronson, L., Pickel, A., Boswick, J. M., Lee, K. L., Ellis, S. G., Califf, R. M., and the TAMI Study Group, 1989, A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. Circulation, 79: 281.

    Article  PubMed  CAS  Google Scholar 

  • Turpie, A. G. G., Gunstensen, J., Hirsh, J., Nelson, H., and Gent, M., 1988, Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement, Lancet, 1: 1242.

    Article  PubMed  CAS  Google Scholar 

  • Turpie, A. G. G., Robinson, J. G., Doyle, D. J., Mulji, A. S., Mishkel, G. J., Sealey, B. J., Cairns, J. A., Skingley, L., Hirsh, J., and Gent, M., 1989, Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction, N. Enql. J. Med., 320: 352.

    Article  CAS  Google Scholar 

  • Veterans Administration Study Investigators, 1973, Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial, J. Am. Med. Assoc., 225: 724.

    Article  Google Scholar 

  • Williams, D. O., Kirby, M. G., McPherson, K., and Phear, D. N., 1896, Anticoagulant treatment in unstable angina, Br. J. Clin. Pract., 40: 114.

    Google Scholar 

  • Working Party on Anticoagulant Therapy in Coronary Thrombosis, 1969, Assessment of short-anticoagulant administration after cardiac infarction, Br. Med. J., i: 335.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Thrombosis and Vascular Research, University of Leuven, Campus Gasthuisberg, O & N, Herestraat 49, B-3000, Leuven, Belgium

    Marc Verstraete

Authors
  1. Marc Verstraete
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Charing Cross and Westminster Medical School, London, UK

    David A. Lane

  2. The Swedish University of Agricultural Sciences, Uppsala, Sweden

    Ingemar Björk

  3. Uppsala University, Uppsala, Sweden

    Ulf Lindahl

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Verstraete, M. (1992). Heparin in the Prevention and Treatment of Arterial Thromboembolism. In: Lane, D.A., Björk, I., Lindahl, U. (eds) Heparin and Related Polysaccharides. Advances in Experimental Medicine and Biology, vol 313. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2444-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2444-5_25

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2446-9

  • Online ISBN: 978-1-4899-2444-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation